Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001193125-23-044051
Filing Date
2023-02-22
Accepted
2023-02-22 06:06:33
Documents
6
Effectiveness Date
2023-02-22

Document Format Files

Seq Description Document Type Size
1 POSASR d468999dposasr.htm POSASR 313956
2 EX-5.1 d468999dex51.htm EX-5.1 25032
3 EX-23.1 d468999dex231.htm EX-23.1 1859
4 EX-FILING FEES d468999dexfilingfees.htm EX-FILING FEES 28913
5 GRAPHIC g468999g03a03.jpg GRAPHIC 49251
6 GRAPHIC g468999page043.jpg GRAPHIC 9214
  Complete submission text file 0001193125-23-044051.txt   451674
Mailing Address 7000 MARINA BLVD BRISBANE CA 94005
Business Address 7000 MARINA BLVD BRISBANE CA 94005 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

EIN.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-255792 | Film No.: 23650441
SIC: 2836 Biological Products, (No Diagnostic Substances)